CTSI Clinical Research Unit

The CTSI has established a Clinical Research Unit (CRU) to support site-based research that spans existing CRUs and data-oriented studies that serve the institution where there is no other clear CRU home.

Scope of Research within the CRU

The CRU will provide infrastructure, resources, and support to help Duke investigators, from any school at Duke University, translate ideas into innovations that improve health. The CTSI Clinical Research Unit (CTSI CRU) is the operating business unit responsible for the integrity, financial accountability, regulatory compliance, quality, and academic productivity of clinical research studies.

The CRU’s organizational focus is on projects that serve the institution and/or span multiple CRUs. Projects are clustered as either:

  1. Site-based research that spans existing CRUs (e.g., when investigators or project scope spans multiple departments or CRUs), or

  2. Data-oriented studies that serve the institution where there is no other clear CRU home (e.g., Biostatistics & Bioinformatics).

Study selection decisions are made within the CRU, as well as the coordination and allocation of resources, and the flow of funds associated with individual studies.

The faculty advisory board will develop clear criteria and the CRU Director will determine appropriateness for projects. Different levels of support will be provided based on the type of research being conducted within the CTSI CRU.

Leadership

Ranee Chatterjee, MD

Ranee Chatterjee, MD, MPH

Director, Clinical Research Unit; Co-Director, Recruitment Innovation Center

To discuss eligibility for inclusion into the CRU and associated fees prior to selecting CTSI in the eIRB, please contact: